Assessment of Cardiovascular Risks due to Methylphenidate in Six Months of Treatment in Children with Attention Deficit and Hyperactivity Disorder-Reference-Cited by-同舟云学术

Assessment of Cardiovascular Risks due to Methylphenidate in Six Months of Treatment in Children with Attention Deficit and Hyperactivity Disorder

Published:2014-09 Issue:3 Volume:24 Page:248-252
ISSN:1017-7833
Container-title:Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
language:en
Short-container-title:Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology

Author:

Ari Mehmet Emre¹,Cetin Ibrahim Ilker¹,Ekici Filiz¹,Kocabas Abdullah¹,Eminoglu Sancar¹,Guney Esra²,Ozturk Onder²,Dinc Gulser Senses²,Goker Zeynep²

Affiliation:

1. Departments of Pediatric Cardiology, Ankara Child Health, Hematology Oncology, Education and Research Hospital, Ankara - Turkey

2. Departments of Child and Adolescent Psychiatry, Ankara Child Health, Hematology Oncology, Education and Research Hospital, Ankara - Turkey

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Psychiatry and Mental health

Link

https://www.tandfonline.com/doi/pdf/10.5455/bcp.20140702010106

Reference21 articles.

1. Attention Deficit Hyperactivity Disorder: Advances in Cognitive, Neurobiological, and Genetic Research

2. Alterations in the Functional Anatomy of Working Memory in Adult Attention Deficit Hyperactivity Disorder

3. Weiss G. Attention deficit hyperactivity disorders. In Lewis M (editor). Child and Adolescent Psychiatry: A Compherensive Textbook. New York: Lippincott Williams and Wilkins; 1991 p. 554–61.

4. ADHD Drugs and Cardiovascular Risk

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD;Molecular Psychiatry;2017-12-12